These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8796579)

  • 1. Theory of proton relaxation in solutions of magnetic nanoparticles, including the superparamagnetic size range.
    Koenig SH; Kellar KE
    Acad Radiol; 1996 Aug; 3 Suppl 2():S273-6. PubMed ID: 8796579
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.
    Tanimoto A; Yuasa Y; Stark DD
    Invest Radiol; 1994 Jun; 29 Suppl 2():S78-80. PubMed ID: 7523329
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast agent for magnetic resonance angiography: experimental evaluation of superparamagnetic iron oxide composed of polysaccharide complex involving chondroitinsulfuric acid.
    Yoshikawa K; Yagi K; Nanjo S; Seno A; Shiono T; Tobe K; Suzuki S
    Acad Radiol; 1996 Aug; 3 Suppl 2():S297-8. PubMed ID: 8796585
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier.
    Evill CA; Wilson AJ; Fletcher MC; Sage MR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S336-8. PubMed ID: 8796597
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton relaxation enhancement.
    Wood ML; Hardy PA
    J Magn Reson Imaging; 1993; 3(1):149-56. PubMed ID: 8428082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H
    Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221
    [No Abstract]   [Full Text] [Related]  

  • 9. Empirical models of transverse relaxation for spherical magnetic perturbers.
    Yung KT
    Magn Reson Imaging; 2003 Jun; 21(5):451-63. PubMed ID: 12878254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles.
    Koenig SH; Kellar KE
    Magn Reson Med; 1995 Aug; 34(2):227-33. PubMed ID: 7476082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast measurements in rodent model tumors.
    Kovar DA; Lipton MJ; Lewis MZ; River JN; Lubich L; Karczmar GS
    Acad Radiol; 1996 Aug; 3 Suppl 2():S384-6. PubMed ID: 8796609
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide.
    Tanimoto A; Pouliquen D; Kreft BP; Stark DD
    J Magn Reson Imaging; 1994; 4(5):653-7. PubMed ID: 7526912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of gadoxetate disodium, manganese dipyridoxal diphosphate, and superparamagnetic iron oxide for enhancement of the liver in dogs.
    Khangure MS; Hua J
    Acad Radiol; 1996 Aug; 3 Suppl 2():S458-60. PubMed ID: 8796629
    [No Abstract]   [Full Text] [Related]  

  • 16. The question of dose for gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
    [No Abstract]   [Full Text] [Related]  

  • 17. The rete mirabile of the eel: a useful model for the study of transcapillary passage of MR contrast agents.
    Siauve N; Cuénod CA; Clément O; Rasio E; Bendayan M; Frija G
    J Magn Reson Imaging; 1999 Feb; 9(2):353-61. PubMed ID: 10077037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramagnetic dextrans as magnetic resonance blood pool tracers.
    Meyer D; Schaefer M; Chambon C; Beaute S
    Invest Radiol; 1994 Jun; 29 Suppl 2():S90-2. PubMed ID: 7523330
    [No Abstract]   [Full Text] [Related]  

  • 19. Basic principles of MR contrast.
    Nelson KL; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):124-36. PubMed ID: 7654392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.